• Presented at European Association of Dermato Oncology (EADO) 2018

  • Collaborator: Pierre Fabre

  • Authors: Malvehy J, Basset Seguin N, Ulianov L, Condomines M, Beauchamp R, Dos Santos R

While organ transplants greatly improve patients’ quality of life, transplant patients must nonetheless take immunosuppressive drugs to prevent organ rejection. Thus, new risks emerge, including a higher chance of developing skin cancer. The objectives of the study were to better understand the organ transplant patients’ behaviors regarding non-melanoma skin cancer (NMSC) risk and to define patients’ expectations regarding a new treatment to prevent NMSC lesions.